The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

CVS Health has secured a major healthcare deal, winning a multi-year pharmacy benefits contract with CalPERS, outbidding rival UnitedHealth. The deal marks a significant win for CVS's Caremark unit ...

In a report released yesterday, Lance Wilkes from Bernstein maintained a Hold rating on CVS Health, with a price target of $72.00. The company’s shares closed yesterday at $63.80. Wilkes covers the ...

The California Public Employees’ Retirement System (CalPERS) has a new pharmacy benefits contract with CVS Caremark, the ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

CalPERS should prioritize proven, effective strategies that cost less and consistently deliver better returns for taxpayers and public employees.

CalPERS is doubling down on its climate-focused strategy. Its "centrally planned" approach will neither address global climate change nor help companies perform better.

CVS plans to appeal the judgment, which comes after a jury ruled that its long-term care pharmacy benefits manager illegally ...

California's top public pension system on Friday said it will more than double its climate-focused investments to $100 billion by 2030 and consider selling stocks in companies with poor plans for ...

Calpers Chief Investment Officer Nicole Musicco has made a push for the $449 billion pension fund to invest directly in companies and bypass private equity giants.

CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement System, known as Calpers.